Kurt R. Schibler, MD
Appointment
Associate Professor of Pediatrics
Email
kurt.schibler@cchmc.org
Phone
513-636-3972
Fax
513-636-4404
Credentials
MD: University of Cincinnati, Cincinnati, Ohio, 1984
Residency: Pediatrics, Indiana University, Indianapolis, Indiana, 1990
Fellowship: Neonatology, University of Utah, Salt Lake City, Utah, 1993
Certification: Pediatrics 1990; Neonatal - Perinatal Mdeicine 1993, renewed 1999.
Awards and Honors
- Subspecialty Award in Developmental Biology, 1992, AFCR/WSCI
- Travel Award, Growth Factors in Perinatal Development, 1992, WSPR
- David W. Smith Pediatric Training Award, 1993, WSPR
- Elected to Society for Pediatric Research, 1996
Research
Kurt Schibler, MD, is the Director of the Neonatology Clinical Research Core and will assume the role of principal investigator of the NICHD Neonatal Network at CCHMC with the competing renewal in 2006. He is a participant in the Necrotizing Enterocolitis (NEC) Working Group whose aims are to develop novel strategies for prevention and treatment of NEC. The following studies exemplify work being conducted by this interdisciplinary group.
- "Development of a statistical model that could predict the risk for NEC", Edward Donovan, MD, Barbara Warner, MD, Jareen Meinzen-Derr, MPH, and Kurt Schibler, MD.
- "Epidermal Growth Factor for the Prevention of Necrotizing Enterocolitis in Premature Infants", Barbara Warner, MD, Brad Warner, MD and Christopher Erwin, PhD.
- "Interleukin-11 Administration For the Prevention of Necrotizing Enterocolitis in Very Low Birth Weight Infants", Kurt Schibler, MD.
Dr. Schibler has also been involved with thematic collaborative efforts with the Center for Epidemiology and Biostatistics in areas of innate mucosal immunity and delineating the role of human milk in infant health. One example of thes endeavors is a study entitled "Correlation of Histo-Blood Group Genotype with Candida Infections among VLBW Infants". This is a secondary study to the NICHD anonymized database linked to anonymized blood sample of studies of genomic impact on morbidity and mortality among high-risk infants. Dr. Schibler is involved in other efforts to incorporate genomic research into NICHD Neonatal Research Network trials.
Research Grants and Contracts
Gerber Foundation, Interleukin-11 administration for the prevention of necrotizing enterocolitis. 06-01-04 to 05-31-06, Principal Investigator.
Publications, Most Recent
Kurt Schibler's publications as listed by PubMed
Yoder, MC, Schibler KR. Developmental biology of the hematopoetic growth factors.Fetal and Neonatal Physiology 2004 Chapter 144
Schibler KR. The mononuclear phagocyte system. Fetal and Neonatal Physiology 2004 Chapter 156
Professional Organization Memberships
- American Academy of Pediatrics, Member
- Society for Pediatric Research, Member
Special Interests
Clinical research in neonatal immune development
Presentations / Invited Lectures, Most Recent
Blood group antigens in the newborn. Neonatology Grand Rounds, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2005.
Related Areas
This person works in these other areas at Cincinnati Children's Hospital Medical Center:
